US equities
|
SPCX
$158.12
▲+6.99%
MU
$917.28
▲+2.37%
NVDA
$221.28
▲+2.22%
TSLA
$386.56
▲+3.44%
META
$698.17
▲+0.56%
SNDK
$1,382.86
▲+1.28%
AMD
$554.70
▲+3.73%
AAPL
$343.94
▲+1.31%
SPCX
$158.12
▲+6.99%
MU
$917.28
▲+2.37%
NVDA
$221.28
▲+2.22%
TSLA
$386.56
▲+3.44%
META
$698.17
▲+0.56%
SNDK
$1,382.86
▲+1.28%
AMD
$554.70
▲+3.73%
AAPL
$343.94
▲+1.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by ISOThrive
ISOThrive Final Phase 2 Results for MHS-1031 Announced at ACG 2026 Demonstrate Statistically Significant and Clinically Meaningful Improvement in Heartburn Frequency and Severity in NERD PPI-Partial Responders
October 12, 2026
From
ISOThrive
Via
ACCESS Newswire